Aspirin use after diagnosis improves survival in older adults with colon cancer

Journal of the American Geriatrics Society

Volumn 61, Issue 5, 2013, Pages 843-844

  Lai, Shih Wei ^a,b   Liao, Kuan Fu ^c,d,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^e CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

BLEEDING; CANCER PROGNOSIS; COLON CANCER; COLORECTAL CANCER; GENE; GENE MUTATION; HUMAN; LETTER; OVERALL SURVIVAL; PIK3CA GENE; TREATMENT RESPONSE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE;

EID: 84877980050     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12236     Document Type: Letter

References (4)

1. Reimers MS, Bastiaannet E, van Herk-Sukel MPP, et al. Aspirin use after diagnosis improves survival in older adults with colon cancer: A retrospective cohort study. J Am Geriatr Soc 2012; 60: 2232-2236.
2. Greystoke A, Mullamitha SA,. How many diseases are colorectal cancer? Gastroenterol Res Pract 2012; 2012: 564741.
3. Liao X, Lochhead P, Nishihara R, et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 2012; 367: 1596-1606.
4. Rothwell PM,. Aspirin in prevention of sporadic colorectal cancer: Current clinical evidence and overall balance of risks and benefits. Recent Results Cancer Res 2013; 191: 121-142.